The Canadian Cannabis LP index consists of companies licensed by Health Canada to cultivate, process or sell cannabis is equal-weighted at the time of the month-end rebalancing and included 8 companies as of 10/31/24 (based on information available as of 10/29). The index includes those companies that are listed in Canada that fully own at least one LP and where the LP is a substantial component of the overall business. In order to qualify, the company’s most recently reported quarterly revenue generated from LP activities must exceeded C$2.5 million. We implemented a new rule on 2/29/24 that the price be at least C$0.10 at the time of rebalancing.